Global Albumin (as Excipient) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 29-Sep-2022
No. of pages: 114
Inquire Before Buying

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Albumin (as Excipient) market is projected to reach US$ 6601.7 million by 2028 from an estimated US$ 4627.7 million in 2022, at a CAGR of 6.1% during 2023 and 2028.

The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.

By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Albumin (as Excipient), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Albumin (as Excipient).

The Albumin (as Excipient) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Albumin (as Excipient) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Albumin (as Excipient) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- CSL

- Grifols

- Takeda

- Octapharma

- Hualan Bio

- CBPO

- Shanghai RAAS

- Kedrion

- LFB Group

- Albumedix

- Biotest

- Merck

- Ventria (InVitria)

- HiMedia

Product Type Insights

Global markets are presented by Albumin (as Excipient) type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Albumin (as Excipient) are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Albumin (as Excipient) Segment by Type

- Human Serum Albumin

- Recombinant Albumin

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Albumin (as Excipient) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Albumin (as Excipient) market.

Albumin (as Excipient) Segment by Application

- Cell Culture Media

- Medical Supplements

- Therapeutics

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Albumin (as Excipient) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin (as Excipient) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Albumin (as Excipient) and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Albumin (as Excipient) industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin (as Excipient)

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Albumin (as Excipient) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Albumin (as Excipient) Product Introduction
1.2 Market by Type
1.2.1 Global Albumin (as Excipient) Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Market by Application
1.3.1 Global Albumin (as Excipient) Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Albumin (as Excipient) Market Size Estimates and Forecasts
2.1.1 Global Albumin (as Excipient) Revenue 2017-2028
2.1.2 Global Albumin (as Excipient) Sales 2017-2028
2.2 Albumin (as Excipient) Market Size by Region: 2022 Versus 2028
2.3 Albumin (as Excipient) Sales by Region (2017-2028)
2.3.1 Global Albumin (as Excipient) Sales by Region: 2017-2022
2.3.2 Global Albumin (as Excipient) Sales Forecast by Region (2023-2028)
2.3.3 Global Albumin (as Excipient) Sales Market Share by Region (2017-2028)
2.4 Albumin (as Excipient) Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Albumin (as Excipient) Revenue by Region: 2017-2022
2.4.2 Global Albumin (as Excipient) Revenue Forecast by Region (2023-2028)
2.4.3 Global Albumin (as Excipient) Revenue Market Share by Region (2017-2028)
3 Global Albumin (as Excipient) by Manufacturers
3.1 Global Top Albumin (as Excipient) Manufacturers by Sales
3.1.1 Global Albumin (as Excipient) Sales by Manufacturer (2017-2022)
3.1.2 Global Albumin (as Excipient) Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Albumin (as Excipient) Manufacturers by Revenue
3.2.1 Global Albumin (as Excipient) Revenue by Manufacturer (2017-2022)
3.2.2 Global Albumin (as Excipient) Revenue Share by Manufacturer (2017-2022)
3.3 Global Albumin (as Excipient) Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Albumin (as Excipient) Manufacturers Covered: Ranking by Revenue
3.4.2 Global Albumin (as Excipient) Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Albumin (as Excipient) Manufacturing Base Distribution, Product Type
3.5.1 Albumin (as Excipient) Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Albumin (as Excipient) Product Type
3.5.3 Date of International Manufacturers Enter into Albumin (as Excipient) Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 CSL
4.1.1 CSL Corporation Information
4.1.2 CSL Description, Business Overview
4.1.3 CSL Albumin (as Excipient) Products Offered
4.1.4 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.1.5 CSL Albumin (as Excipient) Sales by Product in 2021
4.1.6 CSL Albumin (as Excipient) Sales by Application in 2021
4.1.7 CSL Albumin (as Excipient) Sales by Geographic Area in 2021
4.1.8 CSL Recent Developments
4.2 Grifols
4.2.1 Grifols Corporation Information
4.2.2 Grifols Description, Business Overview
4.2.3 Grifols Albumin (as Excipient) Products Offered
4.2.4 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Grifols Albumin (as Excipient) Sales by Product in 2021
4.2.6 Grifols Albumin (as Excipient) Sales by Application in 2021
4.2.7 Grifols Albumin (as Excipient) Sales by Geographic Area in 2021
4.2.8 Grifols Recent Developments
4.3 Takeda
4.3.1 Takeda Corporation Information
4.3.2 Takeda Description, Business Overview
4.3.3 Takeda Albumin (as Excipient) Products Offered
4.3.4 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Takeda Albumin (as Excipient) Sales by Product in 2021
4.3.6 Takeda Albumin (as Excipient) Sales by Application in 2021
4.3.7 Takeda Albumin (as Excipient) Sales by Geographic Area in 2021
4.3.8 Takeda Recent Developments
4.4 Octapharma
4.4.1 Octapharma Corporation Information
4.4.2 Octapharma Description, Business Overview
4.4.3 Octapharma Albumin (as Excipient) Products Offered
4.4.4 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Octapharma Albumin (as Excipient) Sales by Product in 2021
4.4.6 Octapharma Albumin (as Excipient) Sales by Application in 2021
4.4.7 Octapharma Albumin (as Excipient) Sales by Geographic Area in 2021
4.4.8 Octapharma Recent Developments
4.5 Hualan Bio
4.5.1 Hualan Bio Corporation Information
4.5.2 Hualan Bio Description, Business Overview
4.5.3 Hualan Bio Albumin (as Excipient) Products Offered
4.5.4 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Hualan Bio Albumin (as Excipient) Sales by Product in 2021
4.5.6 Hualan Bio Albumin (as Excipient) Sales by Application in 2021
4.5.7 Hualan Bio Albumin (as Excipient) Sales by Geographic Area in 2021
4.5.8 Hualan Bio Recent Developments
4.6 CBPO
4.6.1 CBPO Corporation Information
4.6.2 CBPO Description, Business Overview
4.6.3 CBPO Albumin (as Excipient) Products Offered
4.6.4 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.6.5 CBPO Albumin (as Excipient) Sales by Product in 2021
4.6.6 CBPO Albumin (as Excipient) Sales by Application in 2021
4.6.7 CBPO Albumin (as Excipient) Sales by Geographic Area in 2021
4.6.8 CBPO Recent Development
4.7 Shanghai RAAS
4.7.1 Shanghai RAAS Corporation Information
4.7.2 Shanghai RAAS Description, Business Overview
4.7.3 Shanghai RAAS Albumin (as Excipient) Products Offered
4.7.4 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Shanghai RAAS Albumin (as Excipient) Sales by Product in 2021
4.7.6 Shanghai RAAS Albumin (as Excipient) Sales by Application in 2021
4.7.7 Shanghai RAAS Albumin (as Excipient) Sales by Geographic Area in 2021
4.7.8 Shanghai RAAS Recent Development
4.8 Kedrion
4.8.1 Kedrion Corporation Information
4.8.2 Kedrion Description, Business Overview
4.8.3 Kedrion Albumin (as Excipient) Products Offered
4.8.4 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Kedrion Albumin (as Excipient) Sales by Product in 2021
4.8.6 Kedrion Albumin (as Excipient) Sales by Application in 2021
4.8.7 Kedrion Albumin (as Excipient) Sales by Geographic Area in 2021
4.8.8 Kedrion Recent Development
4.9 LFB Group
4.9.1 LFB Group Corporation Information
4.9.2 LFB Group Description, Business Overview
4.9.3 LFB Group Albumin (as Excipient) Products Offered
4.9.4 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.9.5 LFB Group Albumin (as Excipient) Sales by Product in 2021
4.9.6 LFB Group Albumin (as Excipient) Sales by Application in 2021
4.9.7 LFB Group Albumin (as Excipient) Sales by Geographic Area in 2021
4.9.8 LFB Group Recent Development
4.10 Albumedix
4.10.1 Albumedix Corporation Information
4.10.2 Albumedix Description, Business Overview
4.10.3 Albumedix Albumin (as Excipient) Products Offered
4.10.4 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Albumedix Albumin (as Excipient) Sales by Product in 2021
4.10.6 Albumedix Albumin (as Excipient) Sales by Application in 2021
4.10.7 Albumedix Albumin (as Excipient) Sales by Geographic Area in 2021
4.10.8 Albumedix Recent Development
4.11 Biotest
4.11.1 Biotest Corporation Information
4.11.2 Biotest Description, Business Overview
4.11.3 Biotest Albumin (as Excipient) Products Offered
4.11.4 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Biotest Albumin (as Excipient) Sales by Product in 2021
4.11.6 Biotest Albumin (as Excipient) Sales by Application in 2021
4.11.7 Biotest Albumin (as Excipient) Sales by Geographic Area in 2021
4.11.8 Biotest Recent Development
4.12 Merck
4.12.1 Merck Corporation Information
4.12.2 Merck Description, Business Overview
4.12.3 Merck Albumin (as Excipient) Products Offered
4.12.4 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Merck Albumin (as Excipient) Sales by Product in 2021
4.12.6 Merck Albumin (as Excipient) Sales by Application in 2021
4.12.7 Merck Albumin (as Excipient) Sales by Geographic Area in 2021
4.12.8 Merck Recent Development
4.13 Ventria (InVitria)
4.13.1 Ventria (InVitria) Corporation Information
4.13.2 Ventria (InVitria) Description, Business Overview
4.13.3 Ventria (InVitria) Albumin (as Excipient) Products Offered
4.13.4 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.13.5 Ventria (InVitria) Albumin (as Excipient) Sales by Product in 2021
4.13.6 Ventria (InVitria) Albumin (as Excipient) Sales by Application in 2021
4.13.7 Ventria (InVitria) Albumin (as Excipient) Sales by Geographic Area in 2021
4.13.8 Ventria (InVitria) Recent Development
4.14 HiMedia
4.14.1 HiMedia Corporation Information
4.14.2 HiMedia Description, Business Overview
4.14.3 HiMedia Albumin (as Excipient) Products Offered
4.14.4 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2017-2022)
4.14.5 HiMedia Albumin (as Excipient) Sales by Product in 2021
4.14.6 HiMedia Albumin (as Excipient) Sales by Application in 2021
4.14.7 HiMedia Albumin (as Excipient) Sales by Geographic Area in 2021
4.14.8 HiMedia Recent Development
5 Breakdown Data by Type
5.1 Global Albumin (as Excipient) Sales by Type (2017-2028)
5.1.1 Global Albumin (as Excipient) Sales by Type (2017-2022)
5.1.2 Global Albumin (as Excipient) Sales Forecast by Type (2023-2028)
5.1.3 Global Albumin (as Excipient) Sales Market Share by Type (2017-2028)
5.2 Global Albumin (as Excipient) Revenue Forecast by Type (2017-2028)
5.2.1 Global Albumin (as Excipient) Revenue by Type (2017-2022)
5.2.2 Global Albumin (as Excipient) Revenue Forecast by Type (2023-2028)
5.2.3 Global Albumin (as Excipient) Revenue Market Share by Type (2017-2028)
5.3 Albumin (as Excipient) Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Albumin (as Excipient) Sales by Application (2017-2028)
6.1.1 Global Albumin (as Excipient) Sales by Application (2017-2022)
6.1.2 Global Albumin (as Excipient) Sales Forecast by Application (2023-2028)
6.1.3 Global Albumin (as Excipient) Sales Market Share by Application (2017-2028)
6.2 Global Albumin (as Excipient) Revenue Forecast by Application (2017-2028)
6.2.1 Global Albumin (as Excipient) Revenue by Application (2017-2022)
6.2.2 Global Albumin (as Excipient) Revenue Forecast by Application (2023-2028)
6.2.3 Global Albumin (as Excipient) Revenue Market Share by Application (2017-2028)
6.3 Albumin (as Excipient) Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Albumin (as Excipient) Market Size YoY Growth 2017-2028
7.2 North America Albumin (as Excipient) Market Facts & Figures by Country
7.2.1 North America Albumin (as Excipient) Sales by Country (2017-2028)
7.2.2 North America Albumin (as Excipient) Revenue by Country (2017-2028)
7.3 North America Albumin (as Excipient) Sales by Type
7.4 North America Albumin (as Excipient) Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Albumin (as Excipient) Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Albumin (as Excipient) Market Facts & Figures by Region
8.2.1 Asia-Pacific Albumin (as Excipient) Sales by Region (2017-2028)
8.2.2 Asia-Pacific Albumin (as Excipient) Revenue by Region (2017-2028)
8.3 Asia-Pacific Albumin (as Excipient) Sales by Type
8.4 Asia-Pacific Albumin (as Excipient) Sales by Application
9 Europe
9.1 Europe Albumin (as Excipient) Market Size YoY Growth 2017-2028
9.2 Europe Albumin (as Excipient) Market Facts & Figures by Country
9.2.1 Europe Albumin (as Excipient) Sales by Country (2017-2028)
9.2.2 Europe Albumin (as Excipient) Revenue by Country (2017-2028)
9.3 Europe Albumin (as Excipient) Sales by Type
9.4 Europe Albumin (as Excipient) Sales by Application
10 Latin America
10.1 Latin America Albumin (as Excipient) Market Size YoY Growth 2017-2028
10.2 Latin America Albumin (as Excipient) Market Facts & Figures by Country
10.2.1 Latin America Albumin (as Excipient) Sales by Country (2017-2028)
10.2.2 Latin America Albumin (as Excipient) Revenue by Country (2017-2028)
10.3 Latin America Albumin (as Excipient) Sales by Type
10.4 Latin America Albumin (as Excipient) Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Albumin (as Excipient) Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Albumin (as Excipient) Market Facts & Figures by Country
11.2.1 Middle East and Africa Albumin (as Excipient) Sales by Country (2017-2028)
11.2.2 Middle East and Africa Albumin (as Excipient) Revenue by Country (2017-2028)
11.3 Middle East and Africa Albumin (as Excipient) Sales by Type
11.4 Middle East and Africa Albumin (as Excipient) Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Albumin (as Excipient) Supply Chain Analysis
12.2 Albumin (as Excipient) Key Raw Materials and Upstream Suppliers
12.3 Albumin (as Excipient) Clients Analysis
12.4 Albumin (as Excipient) Sales Channel and Sales Model Analysis
12.4.1 Albumin (as Excipient) Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Albumin (as Excipient) Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Albumin (as Excipient) Distributors
13 Market Dynamics
13.1 Albumin (as Excipient) Industry Trends
13.2 Albumin (as Excipient) Market Drivers
13.3 Albumin (as Excipient) Market Challenges
13.4 Albumin (as Excipient) Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Albumin (as Excipient) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Human Serum Albumin
Table 3. Major Manufacturers of Recombinant Albumin
Table 4. Global Albumin (as Excipient) Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Albumin (as Excipient) Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Albumin (as Excipient) Sales by Region (2017-2022) & (MT)
Table 7. Global Albumin (as Excipient) Sales Forecast by Region (2023-2028) & (MT)
Table 8. Global Albumin (as Excipient) Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Albumin (as Excipient) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Albumin (as Excipient) Sales by Manufacturer (2017-2022) & (MT)
Table 11. Global Albumin (as Excipient) Sales Share by Manufacturer (2017-2022)
Table 12. Albumin (as Excipient) Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Albumin (as Excipient) Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Albumin (as Excipient) Price (2017-2022) & (USD/Kg)
Table 15. Ranking of Global Top Albumin (as Excipient) Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Albumin (as Excipient) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2021)
Table 18. Albumin (as Excipient) Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Albumin (as Excipient) Product Type
Table 20. Date of International Manufacturers Enter into Albumin (as Excipient) Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. CSL Corporation Information
Table 23. CSL Description and Business Overview
Table 24. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 25. CSL Albumin (as Excipient) Product
Table 26. CSL Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 27. CSL Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 28. CSL Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 29. CSL Recent Development
Table 30. Grifols Corporation Information
Table 31. Grifols Description and Business Overview
Table 32. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 33. Grifols Albumin (as Excipient) Product
Table 34. Grifols Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 35. Grifols Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 36. Grifols Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 37. Grifols Recent Development
Table 38. Takeda Corporation Information
Table 39. Takeda Description and Business Overview
Table 40. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 41. Takeda Albumin (as Excipient) Product
Table 42. Takeda Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 43. Takeda Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 44. Takeda Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 45. Takeda Recent Development
Table 46. Octapharma Corporation Information
Table 47. Octapharma Description and Business Overview
Table 48. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 49. Octapharma Albumin (as Excipient) Product
Table 50. Octapharma Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 51. Octapharma Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 52. Octapharma Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 53. Octapharma Recent Development
Table 54. Hualan Bio Corporation Information
Table 55. Hualan Bio Description and Business Overview
Table 56. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 57. Hualan Bio Albumin (as Excipient) Product
Table 58. Hualan Bio Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 59. Hualan Bio Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 60. Hualan Bio Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 61. Hualan Bio Recent Development
Table 62. CBPO Corporation Information
Table 63. CBPO Description and Business Overview
Table 64. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 65. CBPO Albumin (as Excipient) Product
Table 66. CBPO Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 67. CBPO Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 68. CBPO Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 69. Shanghai RAAS Corporation Information
Table 70. Shanghai RAAS Description and Business Overview
Table 71. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 72. Shanghai RAAS Albumin (as Excipient) Product
Table 73. Shanghai RAAS Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 74. Shanghai RAAS Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 75. Shanghai RAAS Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 76. Kedrion Corporation Information
Table 77. Kedrion Description and Business Overview
Table 78. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 79. Kedrion Albumin (as Excipient) Product
Table 80. Kedrion Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 81. Kedrion Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 82. Kedrion Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 83. LFB Group Corporation Information
Table 84. LFB Group Description and Business Overview
Table 85. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 86. LFB Group Albumin (as Excipient) Product
Table 87. LFB Group Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 88. LFB Group Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 89. LFB Group Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 90. Albumedix Corporation Information
Table 91. Albumedix Description and Business Overview
Table 92. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 93. Albumedix Albumin (as Excipient) Product
Table 94. Albumedix Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 95. Albumedix Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 96. Albumedix Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 97. Biotest Corporation Information
Table 98. Biotest Description and Business Overview
Table 99. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 100. Biotest Albumin (as Excipient) Product
Table 101. Biotest Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 102. Biotest Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 103. Biotest Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 104. Merck Corporation Information
Table 105. Merck Description and Business Overview
Table 106. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 107. Merck Albumin (as Excipient) Product
Table 108. Merck Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 109. Merck Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 110. Merck Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 111. Ventria (InVitria) Corporation Information
Table 112. Ventria (InVitria) Description and Business Overview
Table 113. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 114. Ventria (InVitria) Albumin (as Excipient) Product
Table 115. Ventria (InVitria) Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 116. Ventria (InVitria) Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 117. Ventria (InVitria) Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 118. HiMedia Corporation Information
Table 119. HiMedia Description and Business Overview
Table 120. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
Table 121. HiMedia Albumin (as Excipient) Product
Table 122. HiMedia Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Product in 2021
Table 123. HiMedia Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Application in 2021
Table 124. HiMedia Albumin (as Excipient) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2021
Table 125. Global Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 126. Global Albumin (as Excipient) Sales Forecast by Type (2023-2028) & (MT)
Table 127. Global Albumin (as Excipient) Revenue by Type (2017-2022) & (US$ Million)
Table 128. Global Albumin (as Excipient) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 129. Global Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 130. Global Albumin (as Excipient) Sales Forecast by Application (2023-2028) & (MT)
Table 131. Global Albumin (as Excipient) Revenue by Application (2017-2022) & (US$ Million)
Table 132. Global Albumin (as Excipient) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 133. North America Albumin (as Excipient) Sales by Country (2017-2022) & (MT)
Table 134. North America Albumin (as Excipient) Sales by Country (2023-2028) & (MT)
Table 135. North America Albumin (as Excipient) Revenue by Country (2017-2022) & (US$ Million)
Table 136. North America Albumin (as Excipient) Revenue by Country (2023-2028) & (US$ Million)
Table 137. North America Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 138. North America Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 139. Asia-Pacific Albumin (as Excipient) Sales by Region (2017-2022) & (MT)
Table 140. Asia-Pacific Albumin (as Excipient) Sales by Region (2023-2028) & (MT)
Table 141. Asia-Pacific Albumin (as Excipient) Revenue by Region (2017-2028) & (US$ Million)
Table 142. Asia-Pacific Albumin (as Excipient) Revenue by Region (2023-2028) & (US$ Million)
Table 143. Asia-Pacific Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 144. Asia-Pacific Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 145. Europe Albumin (as Excipient) Sales by Country (2017-2022) & (MT)
Table 146. Europe Albumin (as Excipient) Sales by Country (2023-2028) & (MT)
Table 147. Europe Albumin (as Excipient) Revenue by Country (2017-2022) & (US$ Million)
Table 148. Europe Albumin (as Excipient) Revenue by Country (2023-2028) & (US$ Million)
Table 149. Europe Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 150. Europe Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 151. Latin America Albumin (as Excipient) Sales by Country (2017-2022) & (MT)
Table 152. Latin America Albumin (as Excipient) Sales by Country (2023-2028) & (MT)
Table 153. Latin America Albumin (as Excipient) Revenue by Country (2017-2022) & (US$ Million)
Table 154. Latin America Albumin (as Excipient) Revenue by Country (2023-2028) & (US$ Million)
Table 155. Latin America Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 156. Latin America Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 157. Middle East and Africa Albumin (as Excipient) Sales by Country (2017-2022) & (MT)
Table 158. Middle East and Africa Albumin (as Excipient) Sales by Country (2023-2028) & (MT)
Table 159. Middle East and Africa Albumin (as Excipient) Revenue by Country (2017-2022) & (US$ Million)
Table 160. Middle East and Africa Albumin (as Excipient) Revenue by Country (2023-2028) & (US$ Million)
Table 161. Middle East and Africa Albumin (as Excipient) Sales by Type (2017-2022) & (MT)
Table 162. Middle East and Africa Albumin (as Excipient) Sales by Application (2017-2022) & (MT)
Table 163. Albumin (as Excipient) Key Raw Materials, Industry Status and Trend
Table 164. Albumin (as Excipient) Key Raw Materials and Upstream Suppliers
Table 165. Albumin (as Excipient) Clients Status and Trend
Table 166. Albumin (as Excipient) Typical Clients
Table 167. Albumin (as Excipient) Distributors
Table 168. Albumin (as Excipient) Market Trends
Table 169. Albumin (as Excipient) Market Drivers
Table 170. Albumin (as Excipient) Market Challenges
Table 171. Albumin (as Excipient) Market Restraints
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Albumin (as Excipient) Product Picture
Figure 2. Global Albumin (as Excipient) Sales Market Share by Type in 2021 & 2028
Figure 3. Human Serum Albumin Product Picture
Figure 4. Recombinant Albumin Product Picture
Figure 5. Global Albumin (as Excipient) Sales Market Share by Application in 2021 & 2028
Figure 6. Cell Culture Media Examples
Figure 7. Medical Supplements Examples
Figure 8. Therapeutics Examples
Figure 9. Albumin (as Excipient) Report Years Considered
Figure 10. Global Albumin (as Excipient) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Albumin (as Excipient) Market Size 2017-2028 (US$ Million)
Figure 12. Global Albumin (as Excipient) Sales 2017-2028 (MT)
Figure 13. Global Albumin (as Excipient) Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Albumin (as Excipient) Sales Market Share Forecast by Region (2017-2028)
Figure 15. Global Albumin (as Excipient) Revenue Market Share by Region (2017-2028)
Figure 16. Global Albumin (as Excipient) Sales Share by Manufacturer in 2021
Figure 17. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Albumin (as Excipient) Sales Market Share Forecast by Type (2017-2028)
Figure 19. Global Albumin (as Excipient) Revenue Market Share Forecast by Type (2017-2028)
Figure 20. Albumin (as Excipient) Average Selling Price (ASP) by Type (2017-2022) & (USD/Kg)
Figure 21. Global Albumin (as Excipient) Sales Market Share Forecast by Application (2017-2028)
Figure 22. Global Albumin (as Excipient) Revenue Market Share Forecast by Application (2017-2028)
Figure 23. Albumin (as Excipient) Average Selling Price (ASP) by Application (2017-2022) & (USD/Kg)
Figure 24. North America Albumin (as Excipient) Revenue 2017-2028 (US$ Million)
Figure 25. North America Albumin (as Excipient) Sales Market Share by Type (2017-2022)
Figure 26. North America Albumin (as Excipient) Sales Market Share
  • Global Cholesterol Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 98
    Cholesterol is a waxy, fat-like substance that's found in all the cells in your body. Your body needs some cholesterol to make hormones, vitamin D, and substances that help you digest foods. Your body makes all the cholesterol it needs. The report focuses on the Cholesterol market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to ov......
  • Global Soft Capsule Grade Gelatin Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 127
    The report focuses on the Soft Capsule Grade Gelatin market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market......
  • Global Bilberry Extract Market Research Report 2022 - Market Size, Current Insights and Development Trends
    Published: 06-Dec-2022        Price: US 3450 Onwards        Pages: 100
    Bilberry (Vaccinium myrtillus L.) is a perennial,ornamental shrub of Ericaceae. Bilberry contains nutrients which are essentialfor protecting eyes from eyestrain or fatigue, and it can activate bloodcirculation around the eyes. Bilberry tea can be used to treat stomach diseasesand soothe digestive tract traditionally. The report focuses on the Bilberry Extract market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status,......
  • Global Absorbable Hemostat Powder Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 06-Dec-2022        Price: US 5600 Onwards        Pages: 114
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Absorbable Hemostat Powder is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China mark......
  • Global Allografts Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 06-Dec-2022        Price: US 5600 Onwards        Pages: 97
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Allografts estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Allografts is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market for Allografts ......
  • Global Pharmaceutical-Grade Cholesterol Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 06-Dec-2022        Price: US 5600 Onwards        Pages: 80
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Pharmaceutical-Grade Cholesterol is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The Chin......
  • Global Wound Dressing Products Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 06-Dec-2022        Price: US 5600 Onwards        Pages: 115
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Wound Dressing Products is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market ......
  • Global Omega-3, Omega-6, Omega-9 Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 06-Dec-2022        Price: US 5600 Onwards        Pages: 133
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for Omega-3, Omega-6, Omega-9 is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China marke......
  • Global PUFA Oil Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 06-Dec-2022        Price: US 5600 Onwards        Pages: 125
    Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028. The USA market for PUFA Oil is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market for PUFA Oil is......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs